(-)-Eburnamonine
Specifications
4880-88-0CAS Number
225-490-5EC Number
(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-oneIUPAC Name
C19H22N2OChemical Formula
294.4 g/molMolecular Weight
Vinburnine; (-)-Eburnamonine; 4880-88-0; Eburnal; Vinburnina; Vinburninum; DTXSID6045119; 3alpha,16alpha-Eburnamonine; NSC-322920; G54D0HMY25; (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one; DTXCID4025119; (15S,19S)-15-ethyl-1,11-diazapentacyclo(9.6.2.02,7.08,18.015,19)nonadeca-2,4,6,8(18)-tetraen-17-one; Eburnamonine (-)-; RefChem:905548; C04AX17; 225-490-5; Vincamone; Eburnamonine (-); Vinburnine [INN]; Vincanorine; DL-Eburnamonine; Eburnamonine (-)-form; (+/-)-Vincamone; (+/-)-Eburnamonine; Vinburnine, (+/-)-; 2580-88-3; (41S,13aS)-13a-Ethyl-2,3,5,6,13,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(41H)-one; Eburnamonine (+/-)-form [MI]; NSC322920; l-Eburnamonine; Eburnamenin-14(15H)-one, (+/-)-; Eburnal ritardo; cis-Vincamone; 3.alpha.,16.alpha.-eburnamonine; 64UB2942IE; Vinburnine (INN); Vincamona [Spanish]; Vincamona; Vinburninum [INN-Latin]; Vinburnina [INN-Spanish]; (-)-Eburnamonina; CH-846; (-)-Eburnamonina [Spanish]; 3-alpha,16-alpha-Eburnamonine; MLS000758467; EINECS 225-490-5; CH 846; NSC 322920; UNII-G54D0HMY25; UNII-64UB2942IE; (3alpha,16alpha)-Eburnamenin-14(15H)-one; (3-alpha,16-alpha)-Eburnamin-14(15H)-one; Eburnamin-14(15H)-one, (3-alpha,16-alpha)-; NCGC00014750-02; Cervoxan (TN); Prestwick_189; CAS-4880-88-0; Vinburnine (Standard); Spectrum_000379; Vinpocetine Impurity 13; Vinpocetine Impurity 31; Prestwick0_000607; Prestwick1_000607; Prestwick2_000607; Prestwick3_000607; Spectrum2_001504; Spectrum3_001199; Spectrum4_000751; Spectrum5_000938; VINBURNINE [MART.]; NCIStruc1_000941; NCIStruc2_000870; VINBURNINE [WHO-DD]; BSPBio_000514; BSPBio_002877; GTPL345; KBioGR_001102; KBioSS_000859; MLS002153906; DivK1c_000411; SCHEMBL456385; SPBio_001547; SPBio_002733; BPBio1_000566; CHEBI:4740; MEGxp0_001871; orb1306330; CHEMBL1892145; SCHEMBL29391038; ACon1_000004; HMS501E13; HY-B1180R; KBio1_000411; KBio2_000859; KBio2_003427; KBio2_005995; KBio3_002377; NINDS_000411; WYJAPUKIYAZSEM-MOPGFXCFSA-N; GLXC-06666; HMS1569J16; HMS2096J16; HMS2233K13; HMS3713J16; HY-B1180; Tox21_110060; CCG-36740; EBURNAMONINE (-)-FORM [MI]; NCI322920; AKOS015896486; Tox21_110060_1; CS-4789; DB13793; EBC-615989; FD10193; FE65898; IDI1_000411; NCGC00262533-02; NCGC00262533-03; AC-26459; BS-16859; NCI60_002800; SMR001233255; SBI-0051740.P002; NS00003481; C09149; D08676; 3alpha,16alpha-14,15-Dihydroeburnamenin-14-one; F787611; Q2526386; BRD-K40227168-001-03-8; BRD-K40227168-001-06-1; BRD-K40227168-001-12-9; Eburnamenin-14-one, 14,15-dihydro-, (3alpha,16alpha)-; (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18)-tetraen-17-one; EburnamonineSynonyms
